Measuring in vivo tumor pHe with CEST-FISP MRI

Vipul R. Sheth, Yuguo Li, Liu Qi Chen, Christine M. Howison, Chris A. Flask, Mark "Marty" Pagel

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Paramagnetic chemical exchange saturation transfer (PARACEST) MRI contrast agents have been developed that can measure pH in solution studies, but these agents have not previously been detected in vivo. To use the PARACEST agent Yb-DO3A-oAA to measure the extracellular pH (pHe) in tumor tissue, a chemical exchange saturation transfer fast imaging with steady state precession MRI protocol was developed, the saturation period was optimized for sensitive chemical exchange saturation transfer (CEST) detection, and median filtering was used to remove artifacts in CEST spectra. These improvements were used to correlate pH with a ratio of two CEST effects of Yb-DO3A-oAA at a 7 T magnetic field strength (R 2 = 0.99, standard deviation of precision = 0.011 pH units). The PARACEST agent could not be detected in tumor tissue following i.v. injection due to the low sensitivity of in vivo CEST MRI. Yb-DO3A-oAA was detected in tumor tissue and leg muscle after directly injecting the PARACEST agent into these tissues. The measured CEST effects were used to measure a tumor pH of 6.82 ± 0.21 and a leg muscle pH of 7.26 ± 0.14, and parametric pH maps were also generated from these tissue regions. These results demonstrated that tumor pHe can be measured with a PARACEST agent and a rapid CEST-MRI protocol.

Original languageEnglish (US)
Pages (from-to)760-768
Number of pages9
JournalMagnetic Resonance in Medicine
Volume67
Issue number3
DOIs
StatePublished - Mar 2012

Fingerprint

Neoplasms
Leg
Muscles
Magnetic Fields
interleukin-24
Artifacts
Contrast Media
Injections
ytterbium(III)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid 10-o-aminoanilide

Keywords

  • biophysics
  • contrast
  • contrast agents
  • molecular imaging
  • technical research
  • technique development

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Sheth, V. R., Li, Y., Chen, L. Q., Howison, C. M., Flask, C. A., & Pagel, M. M. (2012). Measuring in vivo tumor pHe with CEST-FISP MRI. Magnetic Resonance in Medicine, 67(3), 760-768. https://doi.org/10.1002/mrm.23038

Measuring in vivo tumor pHe with CEST-FISP MRI. / Sheth, Vipul R.; Li, Yuguo; Chen, Liu Qi; Howison, Christine M.; Flask, Chris A.; Pagel, Mark "Marty".

In: Magnetic Resonance in Medicine, Vol. 67, No. 3, 03.2012, p. 760-768.

Research output: Contribution to journalArticle

Sheth, VR, Li, Y, Chen, LQ, Howison, CM, Flask, CA & Pagel, MM 2012, 'Measuring in vivo tumor pHe with CEST-FISP MRI', Magnetic Resonance in Medicine, vol. 67, no. 3, pp. 760-768. https://doi.org/10.1002/mrm.23038
Sheth, Vipul R. ; Li, Yuguo ; Chen, Liu Qi ; Howison, Christine M. ; Flask, Chris A. ; Pagel, Mark "Marty". / Measuring in vivo tumor pHe with CEST-FISP MRI. In: Magnetic Resonance in Medicine. 2012 ; Vol. 67, No. 3. pp. 760-768.
@article{4b4b70e0fca249ad9840f1725e91e054,
title = "Measuring in vivo tumor pHe with CEST-FISP MRI",
abstract = "Paramagnetic chemical exchange saturation transfer (PARACEST) MRI contrast agents have been developed that can measure pH in solution studies, but these agents have not previously been detected in vivo. To use the PARACEST agent Yb-DO3A-oAA to measure the extracellular pH (pHe) in tumor tissue, a chemical exchange saturation transfer fast imaging with steady state precession MRI protocol was developed, the saturation period was optimized for sensitive chemical exchange saturation transfer (CEST) detection, and median filtering was used to remove artifacts in CEST spectra. These improvements were used to correlate pH with a ratio of two CEST effects of Yb-DO3A-oAA at a 7 T magnetic field strength (R 2 = 0.99, standard deviation of precision = 0.011 pH units). The PARACEST agent could not be detected in tumor tissue following i.v. injection due to the low sensitivity of in vivo CEST MRI. Yb-DO3A-oAA was detected in tumor tissue and leg muscle after directly injecting the PARACEST agent into these tissues. The measured CEST effects were used to measure a tumor pH of 6.82 ± 0.21 and a leg muscle pH of 7.26 ± 0.14, and parametric pH maps were also generated from these tissue regions. These results demonstrated that tumor pHe can be measured with a PARACEST agent and a rapid CEST-MRI protocol.",
keywords = "biophysics, contrast, contrast agents, molecular imaging, technical research, technique development",
author = "Sheth, {Vipul R.} and Yuguo Li and Chen, {Liu Qi} and Howison, {Christine M.} and Flask, {Chris A.} and Pagel, {Mark {"}Marty{"}}",
year = "2012",
month = "3",
doi = "10.1002/mrm.23038",
language = "English (US)",
volume = "67",
pages = "760--768",
journal = "Magnetic Resonance in Medicine",
issn = "0740-3194",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Measuring in vivo tumor pHe with CEST-FISP MRI

AU - Sheth, Vipul R.

AU - Li, Yuguo

AU - Chen, Liu Qi

AU - Howison, Christine M.

AU - Flask, Chris A.

AU - Pagel, Mark "Marty"

PY - 2012/3

Y1 - 2012/3

N2 - Paramagnetic chemical exchange saturation transfer (PARACEST) MRI contrast agents have been developed that can measure pH in solution studies, but these agents have not previously been detected in vivo. To use the PARACEST agent Yb-DO3A-oAA to measure the extracellular pH (pHe) in tumor tissue, a chemical exchange saturation transfer fast imaging with steady state precession MRI protocol was developed, the saturation period was optimized for sensitive chemical exchange saturation transfer (CEST) detection, and median filtering was used to remove artifacts in CEST spectra. These improvements were used to correlate pH with a ratio of two CEST effects of Yb-DO3A-oAA at a 7 T magnetic field strength (R 2 = 0.99, standard deviation of precision = 0.011 pH units). The PARACEST agent could not be detected in tumor tissue following i.v. injection due to the low sensitivity of in vivo CEST MRI. Yb-DO3A-oAA was detected in tumor tissue and leg muscle after directly injecting the PARACEST agent into these tissues. The measured CEST effects were used to measure a tumor pH of 6.82 ± 0.21 and a leg muscle pH of 7.26 ± 0.14, and parametric pH maps were also generated from these tissue regions. These results demonstrated that tumor pHe can be measured with a PARACEST agent and a rapid CEST-MRI protocol.

AB - Paramagnetic chemical exchange saturation transfer (PARACEST) MRI contrast agents have been developed that can measure pH in solution studies, but these agents have not previously been detected in vivo. To use the PARACEST agent Yb-DO3A-oAA to measure the extracellular pH (pHe) in tumor tissue, a chemical exchange saturation transfer fast imaging with steady state precession MRI protocol was developed, the saturation period was optimized for sensitive chemical exchange saturation transfer (CEST) detection, and median filtering was used to remove artifacts in CEST spectra. These improvements were used to correlate pH with a ratio of two CEST effects of Yb-DO3A-oAA at a 7 T magnetic field strength (R 2 = 0.99, standard deviation of precision = 0.011 pH units). The PARACEST agent could not be detected in tumor tissue following i.v. injection due to the low sensitivity of in vivo CEST MRI. Yb-DO3A-oAA was detected in tumor tissue and leg muscle after directly injecting the PARACEST agent into these tissues. The measured CEST effects were used to measure a tumor pH of 6.82 ± 0.21 and a leg muscle pH of 7.26 ± 0.14, and parametric pH maps were also generated from these tissue regions. These results demonstrated that tumor pHe can be measured with a PARACEST agent and a rapid CEST-MRI protocol.

KW - biophysics

KW - contrast

KW - contrast agents

KW - molecular imaging

KW - technical research

KW - technique development

UR - http://www.scopus.com/inward/record.url?scp=84857365037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857365037&partnerID=8YFLogxK

U2 - 10.1002/mrm.23038

DO - 10.1002/mrm.23038

M3 - Article

VL - 67

SP - 760

EP - 768

JO - Magnetic Resonance in Medicine

JF - Magnetic Resonance in Medicine

SN - 0740-3194

IS - 3

ER -